Chembio Diagnostics Stock Falls As Q2 Earnings Lag Consensus, Doubt On Ability To Continue As Going Concern
Chembio Diagnostics Inc’s (NASDAQ:CEMI) Q2 sales increased 26% Y/Y to $6.5 million, missing the consensus of $8.5 million. Net product…